Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NT 201 for Glabellar Frown Lines
NCT00694148Phase 3Completed
- Sponsor
- Merz
- Start
- May 2008
- Primary completion
- Jan 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of incobotulinumtoxinA in glabellar rhytides, sponsored by Merz. Started May 2008; status: completed.
02
Drugs
incobotulinumtoxinA
03
Conditions
glabellar rhytides
Beyond the preview
Go deeper on NCT00694148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00694148.